Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern
Jul 17, 2023, 04:38 PM
Share
Subscribe
AP correspondent Jackie Quinn reports on MED Alzheimer’s Drug Eli Lilly.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.